Navigation Links
Nearly Half of Americans Still Suspect Vaccine-Autism Link
Date:1/21/2011

By Amanda Gardner
HealthDay Reporter

THURSDAY, Jan. 20 (HealthDay News) -- Just a slim majority of Americans -- 52 percent -- think vaccines don't cause autism, a new Harris Interactive/HealthDay poll found.

Conversely, 18 percent are convinced that vaccines, like the measles-mumps-rubella (MMR) vaccine, can cause the disorder, and another 30 percent aren't sure.

The poll was conducted last week, following news reports that said the lead researcher of a controversial 1998 study linking autism to the MMR vaccine had used fraudulent research to come to his conclusion.

The poll also found that parents who have lingering doubts about the vaccine were less likely to say that their children were fully vaccinated (86 percent), compared to 98 percent of parents who believe in the safety of vaccines.

Still, the percentage of fully vaccinated children remains high, at 92 percent, the poll found.

"This sounds like a cup half-empty/cup half-full story," said Humphrey Taylor, chairman of The Harris Poll. He noted that while the number of people who believe in a connection between vaccines and autism is "only 18 percent," that nonetheless translates to "millions and millions and millions of people, and it's clear that in some cases that has led them to not vaccinate their children."

Vaccine safety has been a major concern for many parents since the publication of the 1998 study, led by now disgraced British doctor Andrew Wakefield, which concluded that the MMR vaccine caused autism. The journal that originally published the study, The Lancet, has since retracted the paper and Wakefield was recently barred from practicing medicine in Britain.

In recent weeks, another leading British medical journal, BMJ, has published a series of articles purporting to expose deliberate fraud by Wakefield in his handling of the research that served as the basis for the 1998 study.

In the n
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007
2. 29 Clear Channel stations Nationwide Raise Nearly $2.8 Million to Help Save the Lives of Kids Fighting Cancer and Other Deadly Diseases
3. SDI Reports: Nearly a Third Of Physicians Use Handheld and Smartphone Devices to Access Medical Information - Physicians Most Likely to be Using Apple iPhone
4. Rhausler Announces Record Growth of Nearly 700% for its Spinal Implant Devices
5. Case Western Reserve receives nearly $8M to help providers enable adoption of EHRs in Ohio
6. Nearly Half of U.S. Adults Have Heart Risk Factors
7. MDS, a blood cancer, strikes nearly 5 times more Americans than previously thought
8. Radiation Risks Nearly Double for Younger CT Scan Patients
9. Medical costs of cancer have nearly doubled over the past 2 decades
10. Infectious diseases caused two-thirds of the nearly 9 million child deaths globally in 2008
11. Suntricity Power Stations Report Nearly 100% Percent Uptime Suntricity Power Stations using AC power more reliable than standard sun powered solar systems
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nearly Half of Americans Still Suspect Vaccine-Autism Link
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the 19th sweetFrog store located in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, which opened July 1 at Duke’s Travel Plaza, is ...
(Date:7/2/2015)... , ... July 02, 2015 , ... With summer in full swing, Americans are flocking ... one of the top spots for fishing in the world, and it’s easy to understand ... Ontario, Canada has great fish. , Recreational fishing is a huge industry, and Americans ...
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression innovator, ... designed for men. , For style that’s quick on its feet, men will ... is great news for men everywhere because a simple change in socks can dramatically ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... provides comprehensive information on the pipeline products with comparative analysis of the ... therapy (NPWT) with 22 market data tables and 4 figures, spread across ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4
... use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) ... men with prostate cancer, say researchers at Vanderbilt University. ... Health Study included 1,277 participants referred to a urologist ... of the men reported taking an NSAID, mostly aspirin ...
... long-term, randomized clinical trial that included 14,641 physicians who were ... given 400 IU of vitamin E every other day or ... its placebo. , Researchers followed these patients for up ... rates of completion of annual questionnaires, and the confirmation of ...
... characterized as being in "denial" not recognizing the ... to be a form of deception, emerging research suggests ... dysfunction similar to that observed in other neuropsychiatric illnesses. ... relevant research during a symposium on "Impaired Insight into ...
... DPL™ Therapy System for temporary relief of pain. , ... ... announced today that the U.S. Food and Drug Administration (FDA) cleared ... of muscle spasms, temporary relief of minor muscle and joint aches, ...
... A protein known to inhibit the growth of ovarian ... themselves until they die, researchers at The University of Texas ... issue of Cancer Research . , The research team ... is an independent indicator of a woman,s prospects for surviving ...
... Finding may explain why treatment and outcomes are different among ... lung tumors tend to have a different genetic makeup in ... treatment and outcomes are different among races, a new study ... to carry more copies of the epidermal growth factor receptor ...
Cached Medicine News:Health News:Men who take aspirin have significantly lower PSA levels 2Health News:Men who take aspirin have significantly lower PSA levels 3Health News:No protective effect on cancer from long-term vitamin E or vitamin C supplementation 2Health News:'Insight' deficit may explain denial in drug addiction 2Health News:'Insight' deficit may explain denial in drug addiction 3Health News:FDA Clears the DPL (Deep Penetrating Light) Therapy System for Over-the-Counter - Home Use 2Health News:Protein compels ovarian cancer cells to cannibalize themselves 2Health News:Lung Cancer Genetics Different in Black Patients: Study 2
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... shares have been approved for listing and trading on the ... ESSA will begin trading on NASDAQ on July 9, 2015.  ... Exchange under the symbol "EPI". As a result ... each of the Company,s outstanding special warrants issued on January ...
(Date:7/2/2015)... July 2, 2015  Fort Lauderdale-based investment banking ... announce that its Consumer Group completed the sale ... Group plc (ISE: KRZ) ("Kerry"), one of the ... systems, as well as functional ingredients and actives ... Farlie Turner served as the exclusive financial advisor ...
(Date:7/2/2015)... NEW YORK , July 2, 2015 /PRNewswire/ ... of a conspicuously high-growth market segment in hematology ... research publisher said that Roche,s recent unveiling of its ... into the cobas m 511 hematology ... not only capture growth enjoyed by current leader ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... percent of patients treated with VELCADE, cyclophosphamide,and ... Greece, June 28, 2007 /PRNewswire-FirstCall/ -- Millennium,Pharmaceuticals, ... results,from clinical trials of VELCADE based therapies ... (CR) rates in previously,treated multiple myeloma (MM) ...
... 29, 2007 /PRNewswire/ --,The European Myeloma Platform (EMP) ... (lenalidomide) plus the,steroid dexamethasone shows median survival of ... from two large randomized,controlled Phase III trials that ... sites worldwide. These updated results,were presented at the ...
Cached Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: